E Daily Stock Analysis: Takeda Pharmaceutical (TAK)

Put little over $1,000.00 today in TAK at $17.06 per share and we'd buy 59 shares of TAK stock.

A $10 broker fee (if charged) would be paid half at purchase and half at a sale and might cost us about $0.17 per share.

Subtract that maybe $0.17 brokerage cost from my estimated $3.80 gross gain per share results in a net gain of $3.63 X 59 shares = $214.17 for a 21.4% net gain on a $1,006.54 investment.

Takeda Pharmaceutical Co Ltd. (TAK) shows a possible 21.4% net gain including a 5.06% dividend yield. 

Over the next year at this time, a $1000 investment in NVS could generate $50.60 in cash dividends. And a single share bought at yesterday's closing price was about $17.00! So, if TAK is your kind of healthcare investment, their single share price is nearly one-third the annual dividend income from $1,000 invested. This suggests that now may be a good time to invest in Takeda.

All of the estimates above are speculation based on the past history of Takeda Pharmaceutical Co Ltd. (TAK). Only time and money invested in this stock will determine its worth.

1 2
View single page >> |

Disclaimer: This article is for informational and educational purposes only and should not be construed to constitute investment advice. Nothing contained herein shall constitute a solicitation, ...

more
How did you like this article? Let us know so we can better customize your reading experience.

Comments

Leave a comment to automatically be entered into our contest to win a free Echo Show.
Anne Davis 2 months ago Member's comment

Good find!